Pre-eclampsia surgery: Difference between revisions
Jump to navigation
Jump to search
Line 12: | Line 12: | ||
:*[[ Myocardial infarction]] | :*[[ Myocardial infarction]] | ||
:*[[ HELLP syndrome]] | :*[[ HELLP syndrome]] | ||
:* [[Eclampsia]] | |||
:* Suspected acute [[placental abruption]] or [[vaginal bleeding]] in the absence of [[placenta previa]] | |||
:*Nonreassuring [[fetal status]] | :*Nonreassuring [[fetal status]] | ||
Revision as of 11:58, 16 October 2020
Pre-eclampsia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Pre-eclampsia surgery On the Web |
American Roentgen Ray Society Images of Pre-eclampsia surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sara Zand, M.D.[2]
Delivery
Delivery is the mainstay of therapy for preeclampsia in the 37 weeks of gestation or occurrence any of the following:[1]
- Repeated episodes of severe hypertension(blood pressure≥ 160/110 mmHg, despite maintenance treatment with 3 classes of antihypertensive agents
- Progressive thrombocytopenia
- Progressively abnormal renal or liver enzyme tests
- Pulmonary edema
- Abnormal neurological features, such as severe intractable headache, repeated visual scotomata,convulsions,Visual disturbances, motor deficit, alteredsensorium
- Stroke
- Myocardial infarction
- HELLP syndrome
- Eclampsia
- Suspected acute placental abruption or vaginal bleeding in the absence of placenta previa
- Nonreassuring fetal status
References
- ↑ "Gestational Hypertension and Preeclampsia". Obstetrics & Gynecology. 135 (6): e237–e260. 2020. doi:10.1097/AOG.0000000000003891. ISSN 0029-7844.